Michael Kaseta is CFO and COO of Liquidia Corp. Currently has a direct ownership of 412,164 shares of LQDA, which is worth approximately $5.46 Million. The most recent transaction as insider was on Jun 04, 2025, when has been sold 14,777 shares (Common Stock) at a price of $16.97 per share, resulting in proceeds of $250,765. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 412K
1.87% 3M change
30.31% 12M change
Total Value Held $5.46 Million

Michael Kaseta Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2025
SELL
Open market or private sale
$250,765 $16.97 p/Share
14,777 Reduced 3.46%
412,164 Common Stock
Jun 03 2025
BUY
Exercise of conversion of derivative security
-
29,141 Added 6.39%
426,941 Common Stock
Jun 02 2025
SELL
Open market or private sale
$14,379 $16.74 p/Share
859 Reduced 0.22%
397,800 Common Stock
May 30 2025
BUY
Exercise of conversion of derivative security
-
2,344 Added 0.58%
398,659 Common Stock
Apr 14 2025
SELL
Open market or private sale
$112,400 $13.57 p/Share
8,283 Reduced 2.05%
396,315 Common Stock
Mar 03 2025
SELL
Open market or private sale
$13,503 $15.45 p/Share
874 Reduced 0.22%
404,598 Common Stock
Feb 28 2025
BUY
Exercise of conversion of derivative security
-
2,344 Added 0.57%
405,472 Common Stock
Jan 14 2025
SELL
Open market or private sale
$275,298 $11.78 p/Share
23,370 Reduced 5.5%
401,755 Common Stock
Jan 11 2025
BUY
Grant, award, or other acquisition
-
112,797 Added 20.97%
425,125 Common Stock
Dec 02 2024
SELL
Open market or private sale
$12,557 $11.51 p/Share
1,091 Reduced 0.35%
312,328 Common Stock
Nov 30 2024
BUY
Exercise of conversion of derivative security
-
2,343 Added 0.74%
313,419 Common Stock
Oct 14 2024
SELL
Open market or private sale
$43,240 $11.11 p/Share
3,892 Reduced 1.24%
311,076 Common Stock
Sep 03 2024
SELL
Open market or private sale
$10,250 $9.5 p/Share
1,079 Reduced 0.34%
314,968 Common Stock
Aug 30 2024
BUY
Exercise of conversion of derivative security
-
2,344 Added 0.74%
316,047 Common Stock
Jul 12 2024
SELL
Open market or private sale
$48,942 $12.53 p/Share
3,906 Reduced 1.23%
312,389 Common Stock
Jun 03 2024
SELL
Open market or private sale
$15,917 $14.55 p/Share
1,094 Reduced 0.34%
316,295 Common Stock
May 31 2024
BUY
Exercise of conversion of derivative security
-
2,344 Added 0.73%
317,389 Common Stock
Apr 12 2024
SELL
Open market or private sale
$45,722 $14.58 p/Share
3,136 Reduced 0.99%
315,045 Common Stock
Mar 18 2024
SELL
Open market or private sale
$192,466 $15.82 p/Share
12,166 Reduced 3.68%
318,181 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
2,344 Added 0.7%
330,347 Common Stock
Jan 15 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 13.29%
326,250 Common Stock
Jan 11 2024
BUY
Grant, award, or other acquisition
-
93,250 Added 25.24%
276,250 Common Stock
Nov 30 2023
BUY
Exercise of conversion of derivative security
-
2,343 Added 1.26%
183,000 Common Stock
Aug 31 2023
BUY
Exercise of conversion of derivative security
-
2,344 Added 1.28%
180,657 Common Stock
May 31 2023
BUY
Exercise of conversion of derivative security
-
2,344 Added 1.31%
176,597 Common Stock

Also insider at

ALIM
ALIMERA SCIENCES INC Healthcare
HRTX
HERON THERAPEUTICS, INC. Healthcare
MK

Michael Kaseta

CFO and COO
Morrisville, NC

Track Institutional and Insider Activities on LQDA

Follow Liquidia Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LQDA shares.

Notify only if

Insider Trading

Get notified when an Liquidia Corp insider buys or sells LQDA shares.

Notify only if

News

Receive news related to Liquidia Corp

Track Activities on LQDA